AMPE - Ampio Pharmaceuticals to implement 1-for-15 reverse stock split

• Ampio Pharmaceuticals ( OTC:AMPE ) said Tuesday it will implement a 1-for-15 reverse stock split .
• No fractional shares will be outstanding after the reverse split.
• Ampio ( OTC:AMPE ) had ~226.3M shares outstanding prior to the reverse split.
• The reverse stock split will not change the company's authorized shares, which will continue to consist of 310M shares authorized, of which 10M are preferred stock.
• Ampio ( OTC:AMPE ) is implementing the reverse split to increase its share price and lift its trading suspension on the NYSE American.
• The company's stock will begin trading on the OTC Pink Open Market on a post-split basis when markets open on Nov. 10.
• Shares of Ampio ( OTC:AMPE ) ended 26.1% lower on Tuesday.
• The firm in Aug. said it would cut its staff count by over 50% as it ended development of its experimental drug Ampion as part of a strategic review .

For further details see: